Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
Applied Biosciences Corp. Stock Analysis APPB
United States Health Care Nano Cap Applied BioSciences Corp. is a vertically integrated company, which focuses on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics or biopharmaceuticals that target the endocannabinoid system to treat a wide-range of diseases across multiple therapeutic area. The company is headquartered in Carson City, Nevada. The company went IPO on 2015-11-04. The firm operates in one segment for product and service distribution. The company sells consumer products including creams, tinctures, edibles, confections, clothing, apparel, and branded products. The company is involved in the bioceutical and pet health industries, distributing products to the U.S. states and various international markets. The company focuses on investments, consumer brands, and partnerships in the recreational, health and wellness, nutraceutical, and media industries. The company sources products from facilities in California, Colorado, Nevada, and Florida. The firm's brands include Remedi, Remedi Plus, HerbalPet, Champ Organics, and Equine Care. Its subsidiaries include Trace Analytics, Inc., VitaCBD LLC, API Holdings, and Applied Products LLC.
Read More Applied Biosciences Corp (APPB) Chart
Key Statistics of Applied Biosciences Corp (APPB)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
188.00P/E Ratio (TTM)
-52 Week Range
Market Cap
1410.10Avg. Volume
350.00Dividend Yield
-Financial Metrics & Statements of Applied Biosciences Corp (APPB)
FAQ's for Applied Biosciences Corp (APPB)
- According to Musaffa’s Shariah screening methodology, Applied Biosciences Corp (APPB) is currently classified as NOT COVERED as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Applied Biosciences Corp using these criteria to determine its compliance status.
- Muslim investors may consider investing in Applied Biosciences Corp if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Applied Biosciences Corp by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Applied Biosciences Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Applied Biosciences Corp on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.